Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2.
Karolina KaniaWojciech AmbrosiusElzbieta Tokarz KupczykWojciech KozubskiPublished in: Annals of clinical and translational neurology (2021)
Acute disseminated encephalomyelitis (ADEM) is a demyelinating disease, and there are some data that link this event with various vaccinations. We report a young female admitted to the hospital with headache, fever, back pain, nausea, vomiting, and urinary retention. Two weeks prior, she received the first dose of SARS-CoV-2 mRNA vaccine. Brain and spinal cord magnetic resonance imaging (MRI) showed distinctive for ADEM widespread demyelinating lesions. The patient was successfully treated with methylprednisolone.
Keyphrases
- sars cov
- magnetic resonance imaging
- liver failure
- spinal cord
- respiratory failure
- case report
- respiratory syndrome coronavirus
- contrast enhanced
- drug induced
- aortic dissection
- computed tomography
- healthcare
- spinal cord injury
- hepatitis b virus
- diffusion weighted imaging
- magnetic resonance
- neuropathic pain
- low dose
- middle aged
- deep learning
- coronavirus disease
- extracorporeal membrane oxygenation
- multiple sclerosis
- data analysis